Covalent inactivation of lipases.
Ransac
S
S
Laboratoire de Lipolyse Enzymatique, UPR 9025, IFR 1 du CNRS, Marseille, France.
Gargouri
Y
Y
Marguet
F
F
Buono
G
G
Beglinger
C
C
Hildebrand
P
P
Lengsfeld
H
H
Hadváry
P
P
Verger
R
R
D000818:Animals; D001665:Binding Sites; D004220:Disulfides / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D005656:Fungal Proteins / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D007783:Lactones / Q000494:pharmacology; D008049:Lipase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D008958:Models, Molecular; D015394:Molecular Structure; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000494:pharmacology; D000077403:Orlistat; D010179:Pancreas / Q000201:enzymology; D010261:Paraoxon / Q000494:pharmacology; D011487:Protein Conformation; D011817:Rabbits; D013270:Stomach / Q000201:enzymology; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013552:Swine
D004220:Disulfides; D004791:Enzyme Inhibitors; D005656:Fungal Proteins; D007783:Lactones; D009943:Organophosphorus Compounds; D013438:Sulfhydryl Compounds; D000077403:Orlistat; D008049:Lipase; D010261:Paraoxon